FLNA earnings: real EPS beat/miss history, P/E -0.60. Updated 2026-07-23.
Filana Therapeutics (FLNA) Research Hub
Filana Therapeutics (FLNA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 0.7726 USD (-4.49%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.60, market cap 0.05B. This hub links to the full technical, earnings and options research available for FLNA.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.7726 USD (-4.49%) |
| 52-week range | 0.75 USD – 1.32 USD |
| Trend regime | Range |
| 14-day RSI | 22.7 (Oversold) |
| Trailing P/E | -0.60 |
| Market cap | 0.05B |
| Dividend yield | 0.00% |
Available research for FLNA
Covered Call on FLNA: how it works, illustrative setup around the real 0.7726 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on FLNA: how it works, illustrative setup around the real 0.7726 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on FLNA: how it works, illustrative setup around the real 0.7726 USD price, max profit/loss, breakeven and when to use it. Educational.
FLNA technical analysis: range, last 0.7726 USD, RSI 22.7, 52w range 0.75 USD–1.32 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is FLNA in?
Filana Therapeutics (FLNA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is FLNA in an uptrend or downtrend?
As of 2026-09-11, FLNA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is FLNA's trailing P/E ratio?
FLNA's trailing P/E is -0.60, with a market cap of 0.05B. See the earnings research page for full valuation detail.